Exacerbation of psychosis by phenylpropanolamine.
Goodhue
A
A
Bartel
R L
RL
Smith
N B
NB
D000328:Adult; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects*; D014663:Nasal Decongestants / Q000009:adverse effects* / Q000627:therapeutic use; D010259:Paranoid Disorders / Q000139:chemically induced; D017374:Paroxetine / Q000627:therapeutic use; D010546:Perphenazine / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000009:adverse effects* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000209:etiology*; D012008:Recurrence; D019966:Substance-Related Disorders / Q000150:complications*
D014663:Nasal Decongestants; D010665:Phenylpropanolamine; D017374:Paroxetine; D008694:Methamphetamine; D010546:Perphenazine